DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Stein EM, DiNardo CD, Pollyea DA. et al.
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.
Blood 2017;
130 (06) 722-731 . doi:10.1182/blood-2017-04-779405
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.